Oxytocin

The structural pharmacology of OXTR has been characterized by three landmark studies. Waltenspühl et al. (2020) reported the first X-ray crystal structure of human OXTR in complex with an antagonist ligand, identifying an extrahelical cholesterol site between transmembrane helices IV and V and a conserved Mg²⁺ coordination site that functions as a positive allosteric modulator of agonist binding. In 2022, two independent groups resolved active-state OXTR structures by cryo-EM. Meyerowitz et al. (2022) determined the wild-type human OXTR–oxytocin–miniGq/i complex, characterizing how receptor activation involves Mg²⁺ coordination and reorganization of transmembrane helix 7; the study identified a conserved residue governing cation dependence across the oxytocin/vasopressin receptor family. Waltenspühl et al. (2022) reported the oxytocin-bound OXTR–G protein complex at 3.2 Å, characterizing the binding mode, activation mechanism, and subtype selectivity within the OT/AVP receptor family. Together these structures define at atomic resolution how the six-membered disulfide ring and C-terminal tail of oxytocin engage the receptor transmembrane bundle. The foundational receptor biology was reviewed comprehensively by Gimpl and Fahrenholz (2001), whose characterization of OXTR as a class A GPCR requiring Mg²⁺ and cholesterol as allosteric modulators underpins subsequent structural work.

OXTR signaling has been characterized using a range of in vitro assay platforms. In Gq/11-coupled readouts — PLC activation, IP3 generation, and intracellular Ca²⁺ mobilization — OXTR shows robust activity, consistent with its established primary coupling. Meyerowitz et al. (2022) used BRET-based TRUPATH biosensors covering Gq, G11, G15, and Gi/o-family transducers to profile OXTR transducer selectivity, confirming Gq-family dominance and comparatively weaker Gi/o engagement. Cross-reactivity at vasopressin receptor subtypes (V1aR, V1bR, V2R) — established through competitive binding and functional assays — is a recognized parameter in pharmacological study design, as it complicates attribution of observed responses to OXTR specifically. Arrowsmith and Wray (2014) reviewed the signaling pathways downstream of OXTR in myometrial tissue, including IP3-mediated Ca²⁺ store release, store-operated and voltage-operated Ca²⁺ entry, and Ca²⁺ sensitization mechanisms.

Oxytocin's involvement in reproductive physiology has been examined in parturition and lactation models. Fuchs et al. (1982) measured myometrial oxytocin receptor concentration at different gestational stages and in early labor, and examined prostaglandin production in decidual tissue following receptor stimulation, characterizing dual involvement in the context of labor onset. Arrowsmith and Wray (2014) reviewed contractility mechanisms in myometrial tissue, mapping OXTR activation to multiple Ca²⁺ mobilization pathways. In lactation physiology, rodent electrophysiology studies established the pattern of synchronous, intermittent bursting of magnocellular oxytocin neurons associated with the milk-ejection reflex, documenting the role of central oxytocin release within the paraventricular and supraoptic nuclei.

Prairie vole (*Microtus ochrogaster*) models have been a major platform for examining the relationship between the OXTR system and social behavior. Insel and Hulihan (1995) used central administration of oxytocin and an oxytocin receptor antagonist to examine partner-preference formation in non-mating females, characterizing the pharmacological conditions under which partner preference formation was examined in this facultatively monogamous species. Berendzen et al. (2023) took a genetic approach, generating prairie voles homozygous for three distinct loss-of-function *Oxtr* alleles via CRISPR, and examining pair-bonding, parental behaviors, and lactation in OXTR-null animals; the study assessed the degree to which these behaviors depend on OXTR function versus other signaling systems. In human neuroscience, Kirsch et al. (2005) examined amygdala reactivity and its coupling to brainstem regions during social and fear-related processing using neuroimaging; Kosfeld et al. (2005) used a trust-game paradigm to assess social decision-making in a randomized crossover design; and Meyer-Lindenberg et al. (2011) reviewed the translational framework connecting the OXT/AVP system to social cognition research.

The pharmacokinetic profile of oxytocin following intranasal administration has been characterized in human and non-human primate studies. Striepens et al. (2013) reported plasma and cerebrospinal fluid concentration measurements following intranasal administration in humans, documenting the time course of peripheral and central compartment changes. Lee et al. (2018) used a validated LC-MS/MS oxytocin assay in rhesus macaques with paired plasma and CSF sampling across multiple time points following intranasal and intravenous routes, characterizing the plasma-to-CSF relationship and its time course; the study documented that plasma and CSF concentration kinetics were uncorrelated, a recognized parameter when interpreting intranasal administration studies. Overall brain penetrance and the existence of a privileged nose-to-brain delivery route remain subjects of active methodological debate in the literature.

Autism spectrum disorder has been the most extensively studied clinical context for intranasal oxytocin. Early systematic reviews and meta-analyses — Preti et al. (2014) and Ooi et al. (2017) — synthesized the available randomized controlled trial evidence on social cognition and emotion recognition endpoints. Spanos et al. (2020) described the rationale, design, and methods of the SOARS-B study (NCT01944046). Sikich et al. (2021) reported the SOARS-B randomized, placebo-controlled study in children and adolescents with autism spectrum disorder, which examined the primary outcome of social withdrawal as measured by the Aberrant Behavior Checklist-modified Social Withdrawal subscale over a multi-month treatment period. Reviews by Lawson (2017) and McCormack et al. (2021) have also addressed metabolic and feeding-behavior contexts, characterizing appetite-regulatory signaling pathways involving PVN, arcuate (POMC), and caudal-brainstem circuits where oxytocin receptors have been identified.